Christopher Plummer is a Senior Director of Chemistry at Merck, where they leverage extensive experience in drug discovery and small molecule lead optimization across various therapeutic areas. With a proven track record, they have successfully delivered high-quality molecules to advance large pharmaceutical drug discovery programs. Christopher is a co-author on over 30 publications and patents, notably co-inventing the patent for MK-8666, an investigational GPR40 agonist for diabetes. They hold a PhD in Chemistry from Columbia University and a Bachelor's degree in Chemistry from Boston University.
This person is not in any teams
This person is not in any offices